Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	235.13	175.51	134.03	45.61	50.12
Revenue Growth (YoY)	33.97%	30.95%	193.89%	-9.01%	15660.38%
Cost of Revenue	49.03	63.79	50.65	52.23	50.33
Gross Profit	186.1	111.72	83.38	-6.63	-0.21
Selling, General & Admin	172.03	195.04	196.37	173.54	97.27
Other Operating Expenses	1.55	2.48	-1.52	0.57	6.81
Operating Expenses	173.58	197.52	194.85	174.11	104.08
Operating Income	12.52	-85.79	-111.47	-180.74	-104.29
Interest Expense	-4.84	-2.78	-	-	-
Interest & Investment Income	16.97	17	5.12	0.53	1.52
Currency Exchange Gain (Loss)	5.9	-5.9	-	-	-
EBT Excluding Unusual Items	30.55	-77.47	-106.35	-180.21	-102.77
Merger & Restructuring Charges	-23.11	-	-	-	-
Pretax Income	7.45	-77.47	-106.35	-180.21	-102.77
Income Tax Expense	1.7	0.55	1.83	0.76	-0.09
Net Income	5.75	-78.02	-108.18	-180.97	-102.68
Net Income to Common	5.75	-78.02	-108.18	-180.97	-102.68
Shares Outstanding (Basic)	143	143	142	129	118
Shares Outstanding (Diluted)	146	143	142	129	118
Shares Change (YoY)	2.07%	0.93%	9.70%	9.20%	27.36%
EPS (Basic)	0.04	-0.54	-0.76	-1.40	-0.87
EPS (Diluted)	0.04	-0.54	-0.76	-1.40	-0.87
Free Cash Flow	44.11	-34.18	-79.82	-158	-75.53
Free Cash Flow Per Share	0.30	-0.24	-0.56	-1.22	-0.64
Gross Margin	79.15%	63.66%	62.21%	-14.53%	-0.42%
Operating Margin	5.32%	-48.88%	-83.17%	-396.31%	-208.09%
Profit Margin	2.45%	-44.45%	-80.71%	-396.81%	-204.88%
Free Cash Flow Margin	18.76%	-19.47%	-59.55%	-346.44%	-150.70%
EBITDA	31.96	-74.14	-108.76	-177.97	-102.92
EBITDA Margin	13.59%	-42.24%	-81.15%	-	-205.35%
D&A For EBITDA	19.45	11.65	2.71	2.76	1.37
EBIT	12.52	-85.79	-111.47	-180.74	-104.29
EBIT Margin	5.32%	-48.88%	-83.17%	-	-208.09%
Effective Tax Rate	22.77%	-	-	-	-
Revenue as Reported	235.13	175.51	134.03	45.61	50.12

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q